De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Qlucore Beheer

Beheer criteriumcontroles 2/4

De CEO Qlucore's is Carl-Johan Ivarsson, benoemd in Jan2007, heeft een ambtstermijn van 17.75 jaar. bezit rechtstreeks 8.6% van de aandelen van het bedrijf, ter waarde SEK 2.01M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.2 jaar en 5.8 jaar.

Belangrijke informatie

Carl-Johan Ivarsson

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	17.8yrs
Eigendom CEO	8.6%
Management gemiddelde ambtstermijn	10.2yrs
Gemiddelde ambtstermijn bestuur	5.8yrs

Recente managementupdates

Recent updates

CEO

Carl-Johan Ivarsson

17.8yrs

Tenure

Mr. Carl-Johan Ivarsson is Co-Founder, CEO & Director of Qlucore Ab (Publ) since 2007 and also serves as its Chair of Scientific Advisory Board since January 2022. Mr. Ivarsson has a master's degree in ele...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.8yrs	geen gegevens	8.6% SEK 1.9m
Thoas Fioretos	Co-Founder	17.8yrs	geen gegevens	4.58% SEK 1.0m
Johan Rade	Co-Founder	17.8yrs	geen gegevens	8.35% SEK 1.9m
Magnus Fontes	Member of Scientific Advisory Board	no data	geen gegevens	4.63% SEK 1.0m
Cecilia Grotte	Chief Financial Officer	2.7yrs	geen gegevens	geen gegevens
Ulf Ahlfors	Head of Research & Development	2.7yrs	geen gegevens	geen gegevens
Erik Soderback	Head of Diagnostics Sales	2.5yrs	geen gegevens	geen gegevens

10.2yrs

Gemiddelde duur

Ervaren management: Het managementteam van QCORE is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Carl-Johan Ivarsson	Chair of Scientific Advisory Board	17.8yrs	geen gegevens	8.6% SEK 1.9m
Thoas Fioretos	Co-Founder	17.8yrs	geen gegevens	4.58% SEK 1.0m
Magnus Fontes	Member of Scientific Advisory Board	17.8yrs	geen gegevens	4.63% SEK 1.0m
Lars Hockenstrom	Independent Director	1.1yrs	geen gegevens	geen gegevens
Pia Magrhild Gideon	Independent Chairman	15.8yrs	geen gegevens	geen gegevens
Boel Sundvall	Independent Director	5.8yrs	geen gegevens	geen gegevens
Helle Fisker	Independent Director	2.7yrs	geen gegevens	geen gegevens
Albrecht Stenzinger	Member of Scientific Advisory Board	2.8yrs	geen gegevens	geen gegevens
Aurelien de Reynies	Member of Scientific Advisory Board	2.8yrs	geen gegevens	geen gegevens
Solange Peters	Member Scientific Advisory Board	no data	geen gegevens	geen gegevens

5.8yrs

Gemiddelde duur

63.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van QCORE wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).

Qlucore Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Qlucore Appoints Ulf Ahlfors as Head of R&D

Recent updates

New major risk - Financial position

First quarter 2025 earnings released: kr1.87 loss per share (vs kr1.24 loss in 1Q 2024)

Qlucore AB (publ) to Report Q1, 2025 Results on Aug 29, 2024

Full year 2024 earnings released: kr3.89 loss per share (vs kr3.96 loss in FY 2023)

Qlucore Starts Project After Receiving EU Grant to Advance Personalized Cancer Treatment

Third quarter 2024 earnings released: kr0.69 loss per share (vs kr0.72 loss in 3Q 2023)

Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking

Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia

Qlucore AB (publ), Annual General Meeting, Sep 09, 2024

Second quarter 2024 earnings released: kr0.81 loss per share (vs kr1.03 loss in 2Q 2023)

Less than half of directors are independent

Qlucore AB (Publ) Appoints Lars Höckenström as A Member of the Board of Directors

First quarter 2024 earnings released: kr1.24 loss per share (vs kr1.20 loss in 1Q 2023)

New minor risk - Share price stability

Full year 2023 earnings released: kr3.96 loss per share (vs kr2.90 loss in FY 2022)

Qlucore AB (publ) to Report Q1, 2024 Results on Aug 30, 2023

Third quarter 2023 earnings released: kr0.72 loss per share (vs kr0.10 profit in 3Q 2022)

Second quarter 2023 earnings released: kr1.03 loss per share (vs kr1.62 loss in 2Q 2022)

Qlucore AB (publ) to Report First Half, 2023 Results on Nov 28, 2022

Qlucore Software Used in New Project to Prevent Cardiovascular Diseases

Qlucore Receives Patent in Europe

First quarter 2023 earnings released

Qlucore Expands Its Leukemia Diagnostics Solution

Qlucore Ab (Publ) to Report Q1, 2023 Results on Aug 30, 2022

Full year 2022 earnings released

Qlucore Names Erik Söderbäck as Head of Diagnostics Sales

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Qlucore AB (Publ) Appoints Helle Fisker as Regular Member of the Board

Qlucore Appoints Ulf Ahlfors as Head of R&D

Qlucore Announces Management Changes

Qlucore AB (publ) Announces Major New Release for Bioinformatics

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd